Comparative Bioavailability Study of Azithromycin 200mg/5mL Suspension Following a 600mg Dose Under Fed Conditions

• Status: Completed
• Trial end date: 2004-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to demonstrate the bioequivalence of Azithromycin 200mg/5mL oral suspension.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Sandoz
• Treatments: Azithromycin

Criteria

Inclusion Criteria:

• No clinically significant findings on physical exam, medial history or laboratory tests on screening

Exclusion Criteria:

• Positive test for HIV or hepatitis B and C

• Treatment for Drug or alcohol abuse

• Any other important criteria in the protocol